The Polysaccharide, PGG-Glucan, Enhances Human Myelopoiesis by Direct Action Independent of and Additive to Early-Acting Cytokines

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Acta Haematologica

• Publication date

  1999-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000040972PMID 10529508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mobilization of Peripheral Blood Progenitor Cells by Betafectin® PGG‐Glucan Alone and in Combination with Granulocyte Colony‐Stimulating Factor

  1998cited by this paper
• PGG‐Glucan activates NF‐κB‐like and NF‐IL‐6‐like transcription factor complexes in a murine monocytic cell line

  1997cited by this paper
• A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients.

  1994cited by this paper
• Randomized Phase I/II Trial of a Macrophage‐Specific Immunomodulator (PGG‐Glucan) in High‐Risk Surgical Patients

  1994cited by this paper
• Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo

  1992cited by this paper
• Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor.

  1990cited by this paper
• Effect of glucan on neutrophil dynamics and immune function in Escherichia coli peritonitis.

  1988cited by this paper
• Glucan: Mechanisms Involved in Its “Radioprotective” Effect

  1987cited by this paper
• A short-duration polyethylene glycol fusion technique for increasing production of monoclonal antibody-secreting hybridomas.

  1985cited by this paper
• Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low-dose glucan treatment.

  1983cited by this paper
• Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan.

  1983cited by this paper
• The role of macrophages and T-lymphocytes in glucan-mediated alteration of murine hemopoiesis.

  1981cited by this paper
• Modulation of murine hemopoiesis by glucan.

  1980cited by this paper
• Comparative tumor‐inhibitory and anti‐bacterial activity of soluble and particulate glucan

  1979cited by this paper
• Glucan:inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models.

  1978cited by this paper
• Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice

  1978cited by this paper
• Glucan-activated macrophages: functional characteristics and surface morphology.

  1978cited by this paper
• Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan.

  1978cited by this paper
• Effect of glucan, a macrophage activator, on murine hemopoietic cell proliferation in diffusion chambers in mice.

  1978cited by this paper
• Effect of glucan on granulopoiesis and macrophage genesis in mice.

  1977cited by this paper
• RECOGNITION FACTORS AND NONSPECIFIC MACROPHAGE ACTIVATION IN THE TREATMENT OF NEOPLASTIC DISEASE *

  1976cited by this paper
• Macrophage-mediated destruction of human malignant cells in vivo.

  1975cited by this paper

• Polysaccharides in food industry

  2021cites this paper
• Immunomodulatory activities of polysaccharides from Ganoderma on immune effector cells.

  2020cites this paper
• The mechanisms for the radioprotective effect of beta-d-glucan on high linear-energy-transfer carbon ion irradiated mice.

  2019cites this paper
• Modulatory role of Saccharomyces cerevisiae against cadmium-induced genotoxicity in mice

  2017cites this paper
• Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future

  2017cites this paper
• InFiQuS: Making the Best of Leftovers

  2016cites this paper
• Mesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model

  2016cites this paper
• Oral Intake of Carboxymethyl-Glucan (CM-G) from Yeast (Saccharomyces uvarum) Reduces Malondialdehyde Levels in Healthy Men

  2015cites this paper
• An Evidence-Based Systematic Review of Beta-Glucan by the Natural Standard Research Collaboration

  2014cites this paper
• Effects of glucan on bone marrow.

  2014influential citation
• In vivo evaluation of the antimutagenic and antigenotoxic effects of β-glucan extracted from Saccharomyces cerevisiae in acute treatment with multiple doses

  2013cites this paper
• Modulation of Animal and Human Hematopoiesis by β-Glucans: A Review

  2011cites this paper
• Effects of carboxymethyl-glucan from Saccharomyces cerevisiae on the peripheral blood cells of patients with advanced prostate cancer

  2010cites this paper
• beta-Glucan administration enhances disease resistance and some innate immune responses in zebrafish (Danio rerio).

  2009cites this paper
• Maitake Beta-Glucan Enhances Umbilical Cord Blood Stem Cell Transplantation in the NOD/SCID Mouse

  2009cites this paper
• [The biological activity of beta-glucans].

  2009cites this paper
• β-glucan administration enhances disease resistance and some innate 1 immune responses in zebrafish ( Danio rerio ) 2 3

  2009cites this paper
• beta-Glucans in promoting health: prevention against mutation and cancer.

  2008cites this paper
• A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy

  2008cites this paper
• Chinese Medicine and Biomodulation in Cancer Patients (Part One)

  2008cites this paper
• Orally administered marine (1-->3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity.

  2007cites this paper
• Glucan and resveratrol complex--possible synergistic effects on immune system.

  2007cites this paper
• Argumentos a favor de la incorporación de los β-D-glucanos a la alimentación

  2007cites this paper
• Oral administration of a new soluble branched β‐1,3‐D‐glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers

  2006cites this paper
• Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury.

  2006cites this paper
• Enhancement of Umbilical Cord Blood Cell Hematopoiesis by Maitake Beta-Glucan Is Mediated by Granulocyte Colony-Stimulating Factor Production

  2006cites this paper
• RADIATION PROTECTANTS: CURRENT STATUS AND FUTURE PROSPECTS

  2005cites this paper
• Measurement of IL-10 serum levels in BALB/c mice treated with beta-1,3 polyglucose or sulfadiazine and acutely infected by Toxoplasma gondii

  2005cites this paper
• Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.

  2004cites this paper
• Fractionation of Aloe vera L. inner gel, purification and molecular profiling of activity.

  2004cites this paper
• BTR2003: Unified Science & Technology for Reducing Biological Threats and Countering Terrorism March 19-21, 2003 Oral WGP Beta Glucan Treatment Accelerates Myeloid Recovery after Radiation Exposure

  2003cites this paper